Latest Oncopeptides News & Updates

See the latest news and media coverage for Oncopeptides. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Oncopeptides

Biotech company developing targeted cancer therapies

oncopeptides.com
Headquarters
Stockholm, Sweden
Founded year
2000
Company type
Public company
Number of employees
80–200

Last updated

Latest news about Oncopeptides

In short: Oncopeptides doubled its 2025 sales and expanded its global reach through new partnerships and clinical progress despite US regulatory setbacks.

Company announcements

  • Oncopeptides

    Oncopeptides publishes the 2025 Annual Report

    The report highlights progress, Pepaxti growth, and PDC platform potential. It is available as PDF on the website.

  • Oncopeptides

    Oncopeptides announces Annual General Meeting

    The meeting occurs on May 21, 2026, in Stockholm. It covers board elections, remuneration guidelines, incentive programs, and share issuance authorization.

  • Oncopeptides

    Oncopeptides publishes real-world evidence on refractory multiple myeloma

    Study shows 41% response rate in advanced patients, supports treatment sequencing, and manageable safety in elderly. Reinforces exploring new approaches.

  • Oncopeptides

    Oncopeptides announces updated shares and votes

    After rights issue, shares total 395,287,003, with 382,562,006.5 votes. Share capital increases to SEK 43,920,779.894805.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Oncopeptides

Track Oncopeptides and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Oncopeptides competitors & trending companies

Browse news for competitors to Oncopeptides and other trending companies.